Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 3/20 | 0.52 |
| ▸ | SLC26A3 | P40879 | 4/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | ACHE | P22303 | 3/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5806930 | 0.88 | MAOB (0.50) | MAOBACHEKDM4EALDH1A1GAA | |
| SCHEMBL7302123 | 0.80 | MAOB (0.77) | MAOBACHE | |
| SCHEMBL7293972 | 0.77 | MAOB (0.56) | MAOBRAB9AACHEMAPT | |
| SCHEMBL7291407 | 0.75 | MAOB (0.64) | MAOBACHEKDM4EALDH1A1HPGD | |
| SCHEMBL7296443 | 0.74 | ALDH1A1 (0.64) | MAOBRAB9AKDM4EALDH1A1POLB | |
| SCHEMBL7293827 | 0.74 | MAOB (0.65) | MAOBACHEKDM4EALDH1A1GAA | |
| SCHEMBL7294868 | 0.73 | MAOB (0.64) | MAOBRAB9AACHEKDM4EALDH1A1 | |
| SCHEMBL7300790 | 0.72 | KDM4E (0.57) | MAOBRAB9AKDM4EALDH1A1HPGD | |
| SCHEMBL7300401 | 0.72 | TDP1 (0.62) | MAOBRAB9AKDM4EALDH1A1POLB | |
| SCHEMBL5617595 | 0.71 | MAOB (0.50) | MAOBACHEKDM4EALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0363796-B1 | HETEROCYCLICALLY SUBSTITUTED ALKOXYCOUMARINES, METHOD FOR THEIR PREPARATION AND THERAPEUTICAL AGENTS CONTAINING SAME | BASF Aktiengesellschaft (DE) | 1993-08-11 | — | — | EP | disclosed |
| US-5227392-A | Monoamine oxidase inhibitors | BASF AKTIENGESELLSCHAFT (DE) | 1993-07-13 | — | — | US | disclosed |
| US-5073563-A | Enzyme inhibitors, CNS | BASF AKTIENGESELLSCHAFT (DE) | 1991-12-17 | — | — | US | disclosed |
| EP-0363796-A1 | Heterocyclically substituted alkoxycoumarines, method for their preparation and therapeutical agents containing same | BASF Aktiengesellschaft (DE) | 1990-04-18 | — | — | EP | disclosed |